C4 Therapeutics, Inc. (CCCC)
2.43
-0.04
(-1.62%)
USD |
NASDAQ |
Dec 15, 16:00
2.45
+0.02
(+0.82%)
After-Hours: 20:00
C4 Therapeutics Profit Margin (Quarterly): -286.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 21.32% |
| Biogen, Inc. | 19.00% |
| Amicus Therapeutics, Inc. | 10.24% |
| GT Biopharma, Inc. | -- |
| Nurix Therapeutics, Inc. | -1.09K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.62% |
| Return on Assets | -37.05% |
| Return on Invested Capital | -45.66% |
| Gross Profit Margin (Quarterly) | 81.55% |
| Operating Margin (Quarterly) | -210.9% |
| Return on Net Operating Assets | -182.0% |